306 related articles for article (PubMed ID: 17886623)
1. Residual renal function plays an important role in regulating parathyroid hormone in patients on continuous ambulatory peritoneal dialysis.
Okada S; Inoue T; Nakamoto H; Ikeda N; Sugahara S; Shoda J; Okada H; Kanno Y; Suzuki H
Adv Perit Dial; 2007; 23():150-4. PubMed ID: 17886623
[TBL] [Abstract][Full Text] [Related]
2. Low prevalence of hyperphosphatemia independent of residual renal function in peritoneal dialysis patients.
Dong J; Wang H; Wang M
J Ren Nutr; 2007 Nov; 17(6):389-96. PubMed ID: 17971311
[TBL] [Abstract][Full Text] [Related]
3. Residual renal function in children treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis--a preliminary study.
Roszkowska-Blaim M; Skrzypczyk P; Drozdz D; Pietrzyk JA
Adv Perit Dial; 2009; 25():103-9. PubMed ID: 19886329
[TBL] [Abstract][Full Text] [Related]
4. Secondary hyperparathyroidism and risk factors in patients undergoing peritoneal dialysis in a tertiary hospital.
Suwan N
J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S101-5. PubMed ID: 22043575
[TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
6. Hyperphosphatemia in Chinese peritoneal dialysis patients with and without residual kidney function: what are the implications?
Wang AY; Woo J; Sea MM; Law MC; Lui SF; Li PK
Am J Kidney Dis; 2004 Apr; 43(4):712-20. PubMed ID: 15042549
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
[TBL] [Abstract][Full Text] [Related]
8. Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study.
Kim S; Oh J; Kim S; Chung W; Ahn C; Kim SG; Oh KH
Nephrol Dial Transplant; 2009 Sep; 24(9):2899-908. PubMed ID: 19258384
[TBL] [Abstract][Full Text] [Related]
9. Disordered mineral metabolism is not a risk factor for loss of residual renal function in dialysis patients.
Noordzij M; Voormolen NM; Boeschoten EW; Dekker FW; Bos WJ; Krediet RT; Korevaar JC;
Nephrol Dial Transplant; 2009 May; 24(5):1580-7. PubMed ID: 19155531
[TBL] [Abstract][Full Text] [Related]
10. Plasma calcitonin concentration in patients treated with chronic dialysis: differences between hemodialysis and CAPD.
Martínez ME; Miguel JL; Gómez P; Selgas R; Salinas M; Gentil M; Mateos F; Montero JL; Sánchez Sicilia L
Clin Nephrol; 1983 May; 19(5):250-3. PubMed ID: 6851265
[TBL] [Abstract][Full Text] [Related]
11. Reversibility of parathyroid gland suppression in CAPD patients with low i-PTH levels.
Montenegro J; Saracho R; González O; Moina I; Martínez I
Clin Nephrol; 1997 Dec; 48(6):359-63. PubMed ID: 9438094
[TBL] [Abstract][Full Text] [Related]
12. [Significance of residual renal functions of patients with end-stage renal failure undergoing continuous ambulatory peritoneal dialysis].
Kasai K; Kobayashi H; Terawaki H; Hirano K; Ohtsuka Y; Kato N; Kawaguchi Y; Hosoya T
Nihon Jinzo Gakkai Shi; 1997 Dec; 39(8):783-9. PubMed ID: 9483944
[TBL] [Abstract][Full Text] [Related]
13. Predictors of residual renal function loss in peritoneal dialysis: is previous renal transplantation a risk factor?
Bernardo A; Fonseca I; Rodrigues A; Carvalho MJ; Cabrita A
Adv Perit Dial; 2009; 25():110-4. PubMed ID: 19886330
[TBL] [Abstract][Full Text] [Related]
14. Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients.
Mazzaferro S; Pasquali M; Farcomeni A; Vestri AR; Filippini A; Romani AM; Barresi G; Pugliese F
Nephrol Dial Transplant; 2008 Jul; 23(7):2319-23. PubMed ID: 18281320
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of body size indices, residual renal function, and peritoneal transport characteristics in continuous ambulatory peritoneal dialysis.
Twardowski ZJ; Moore HL; Prowant BF; Satalowich R
Adv Perit Dial; 2009; 25():155-64. PubMed ID: 19886338
[TBL] [Abstract][Full Text] [Related]
16. Systemic and intraperitoneal proinflammatory cytokine profiles in patients on continuous ambulatory peritoneal dialysis.
Maksic D; Vasilijic S; Colic M; Stankovic-Popovic V; Bokonjic D
Adv Perit Dial; 2009; 25():50-5. PubMed ID: 19886317
[TBL] [Abstract][Full Text] [Related]
17. Residual renal function: considerations on its importance and preservation in dialysis patients.
Chandna SM; Farrington K
Semin Dial; 2004; 17(3):196-201. PubMed ID: 15144545
[TBL] [Abstract][Full Text] [Related]
18. [Dynamic changes in calcium and phosphate plasma concentrations in the patients on peritoneal dialysis].
Jovanović N; Lausević M; Stojimirović B
Vojnosanit Pregl; 2006 Jan; 63(1):27-30. PubMed ID: 16471245
[TBL] [Abstract][Full Text] [Related]
19. Recovery of renal function in patients treated by CAPD.
Rottembourg J; Issad B; Allouache M; Jacobs C
Adv Perit Dial; 1989; 5():63-6. PubMed ID: 2577429
[TBL] [Abstract][Full Text] [Related]
20. PTH levels correlate with mental performance in CAPD.
Garcia-Maldonado M; Patterson D; Smith ZM
Adv Perit Dial; 1991; 7():234-6. PubMed ID: 1680433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
